88 related articles for article (PubMed ID: 11818364)
21. Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia.
Beamer CA; Brooks DM; Lurie DI
J Neurosci Res; 2006 May; 83(7):1220-30. PubMed ID: 16528752
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation.
Schulz R; Heusch G
J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565
[TBL] [Abstract][Full Text] [Related]
23. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
Daugherty A; Rateri DL; Lu H; Inagami T; Cassis LA
Circulation; 2004 Dec; 110(25):3849-57. PubMed ID: 15596561
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.
Caso JR; Pradillo JM; Hurtado O; Lorenzo P; Moro MA; Lizasoain I
Circulation; 2007 Mar; 115(12):1599-608. PubMed ID: 17372179
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
26. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.
Hughes PM; Allegrini PR; Rudin M; Perry VH; Mir AK; Wiessner C
J Cereb Blood Flow Metab; 2002 Mar; 22(3):308-17. PubMed ID: 11891436
[TBL] [Abstract][Full Text] [Related]
27. Early NFkappaB activation is inhibited during focal cerebral ischemia in interleukin-1beta-converting enzyme deficient mice.
Huang FP; Wang ZQ; Wu DC; Schielke GP; Sun Y; Yang GY
J Neurosci Res; 2003 Sep; 73(5):698-707. PubMed ID: 12929137
[TBL] [Abstract][Full Text] [Related]
28. Transgenic Mice Overexpressing Human Angiotensin I Receptor Gene Are Susceptible to Stroke Injury.
Jain S; Tulsulkar J; Rana A; Kumar A; Shah ZA
Mol Neurobiol; 2016 Apr; 53(3):1533-1539. PubMed ID: 25652270
[TBL] [Abstract][Full Text] [Related]
29. GPR39 Knockout Worsens Microcirculatory Response to Experimental Stroke in a Sex-Dependent Manner.
Xu Y; Zhang WH; Allen EM; Fedorov LM; Barnes AP; Qian ZY; Bah TM; Li Y; Wang RK; Shangraw RE; Alkayed NJ
Transl Stroke Res; 2023 Oct; 14(5):766-775. PubMed ID: 36181628
[TBL] [Abstract][Full Text] [Related]
30. Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis.
Ström JO; Strid T; Hammarström S
BMC Neurosci; 2012 Nov; 13():146. PubMed ID: 23194405
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II as a player in fibrosis.
Matsusaka T; Katori H; Miyazaki Y; Niimura F; Ichikawa I
Nephrol Dial Transplant; 2000; 15 Suppl 6():64-5. PubMed ID: 11143995
[No Abstract] [Full Text] [Related]
32. Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo.
Raida Z; Hundahl CA; Kelsen J; Nyengaard JR; Hay-Schmidt A
Exp Transl Stroke Med; 2012 Aug; 4(1):15. PubMed ID: 22901501
[TBL] [Abstract][Full Text] [Related]
33. Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia.
Saavedra JM; Ito T; Nishimura Y
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S102-S109. PubMed ID: 28095215
[No Abstract] [Full Text] [Related]
34. Studies of intracellular angiotensin II.
Re RN; Cook JL
Methods Mol Biol; 2015; 1234():1-8. PubMed ID: 25304343
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity for an angiotensin II-like peptide in the human brain.
Quinlan JT; Phillips MI
Brain Res; 1981 Jan; 205(1):212-8. PubMed ID: 7008900
[No Abstract] [Full Text] [Related]
36. The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury.
Villapol S; Janatpour ZC; Affram KO; Symes AJ
Neurotherapeutics; 2023 Oct; 20(6):1565-1591. PubMed ID: 37759139
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of Angiotensin II Type 2 Receptor Modulates Pro-Inflammatory Response in Microglia and Macrophages: Therapeutic Implications for the Treatment of Stroke.
Alshammari A; Han Y; Jones TW; Pillai B; Zhang D; Ergul A; Somanath PR; Fagan SC
Life (Basel); 2023 May; 13(6):. PubMed ID: 37374057
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotection in Stroke-Focus on the Renin-Angiotensin System: A Systematic Review.
Andone S; Bajko Z; Motataianu A; Maier S; Barcutean L; Balasa R
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409237
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-(1-7) as a Potential Therapeutic Strategy for Delayed Cerebral Ischemia in Subarachnoid Hemorrhage.
Annoni F; Moro F; Caruso E; Zoerle T; Taccone FS; Zanier ER
Front Immunol; 2022; 13():841692. PubMed ID: 35355989
[TBL] [Abstract][Full Text] [Related]
40. Molecular Mechanisms of Neuroimmune Crosstalk in the Pathogenesis of Stroke.
Choi YH; Laaker C; Hsu M; Cismaru P; Sandor M; Fabry Z
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
